Looking for volunteers
QLESP Block for Pain Control in Robotic Partial Nephrectomy
NCT07704970 · Huazhong University of Science and Technology · Updated 25 Sept 2026
- What is being tested
- ropivacaine (local infiltration); ropivacaine
- For
- Renal Cell Carcinoma (Kidney Cancer); Postoperative Pain; Nerve Block
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 80 years. About 120 people. The full rules are on the registry page.
- Where
- China
- When
- Starts or started 22 Sept 2026, ends 31 March 2027. Registered 15 July 2026.
- Results
- None posted yet.
In the researchers' words
The goal of this clinical trial is to learn if an ultrasound-guided nerve block called QLESP works to reduce pain and the need for strong pain medicines after robotic kidney surgery in adults. The main questions it aims to answer are: 1. Does QLESP reduce the total amount of opioid pain medicine participants need in the first 48 hours after surgery? 2. Does QLESP lower pain scores and improve recovery quality after surgery? Researchers will compare participants who receive QLESP block to participants who receive the same numbing medicine injected only at the surgical wound sites. Participants will: 1. Be randomly assigned to receive either QLESP or local wound injection before surgery. 2. Have a patient-controlled pain pump for 48 hours after surgery. 3. Complete pain scores and recovery quality questionnaires at 2, 6, 12, 24, 48, and 72 hours after surgery. 4. Be followed until hospital discharge.
Sites
- Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyWuhan, Hubei, China